A world leader in genomics, but England’s patients face obst...

England is at the forefront of the genomics revolution – but NHS patients are unlikely to be the first to benefit.

Patient involvement in HTA

Considering the essential role of patient experience in HTA and the role of pharma.

Patient centricity: Identifying how Boehringer Ingelheim UK ...

Boehringer Ingelheim UK provides an update on its patient centricity initiative ahead of a new white paper later this year.

From ideals to execution: the reality of patient-centricity ...

An integrated digital ecosystem to support patient outcomes,...

Demand for improved pharmaceutical care that enhances the patient experience is ever increasing, and meanwhile outcomes-based medicine has become a key focus for health authorities around the world

Patient centricity: How does Boehringer Ingelheim UK measure...

Patient centricity is a subject that is massively talked about but few can 'walk the talk'.